AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FENNEC PHARMACEUTICALS INC. Director's Dealing 2023

Apr 18, 2023

35599_dirs_2023-04-17_3b4f08e3-b08d-494e-adbf-b8fbb9dd99ee.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2023-04-17

Reporting Person: RALLIS CHRIS A (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-17	Common Shares	M	1700	$2.94	Acquired	33777	Direct
2023-04-17	Common Shares	F	986	$8.34	Disposed	32791	Direct

Footnotes

F1: Represents options granted May 17, 2013, with a $2.94 strike price aand expiration of May 17, 2023.

F2: Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligation in connectionwith the exercise of 1,700 shares from a May 2013 grant.